Antje Gasparic

N-Glucuronidation of the antiepileptic drug retigabine: results from studies with human volunteers, heterologously expressed human UGTs, human liver, kidney, and liver microsomal membranes of Crigler-Najjar type II

Jürgen Borlak, Antje Gasparic, Mathias Locher et al. · Metabolism · 2006 · 57 citations

Crigler-najjar Type Ii, Medicinal Chemistry, Human Volunteers +6

Imepitoin as novel treatment option for canine idiopathic epilepsy: pharmacokinetics, distribution, and metabolism in dogs

Chris Rundfeldt, Antje Gasparic · Journal of Veterinary Pharmacology and Therapeutics · 2014 · 23 citations · Full text

Novel Treatment Option, Imepitoin Tablets, Veterinary Behavioral Medicine +14

An automated, highly sensitive LC-MS/MS assay for the quantification of the opiate antagonist naltrexone and its major metabolite 6β-naltrexol in dog and human plasma

Claudia Clavijo, Jamie Bendrick‐Peart, Y ZHANG et al. · Journal of Chromatography B · 2008 · 21 citations

Pharmacological Study, Pharmacology, Quantitative Pharmacology +9

Disposition and Metabolism of Cetrorelix, A Potent Luteinizing Hormone-Releasing Hormone Antagonist, in Rats and Dogs1

Martin Schwahn, Hubert Schupke, Antje Gasparic et al. · Drug Metabolism and Disposition · 2000 · 20 citations

Intra-individual variability and circadian rhythm of vascular endothelial growth factors in subjects with normal glucose tolerance and type 2 diabetes

M Hanefeld, Katrin Engelmann, Dieter Appelt et al. · PLoS ONE · 2017 · 17 citations · Full text